Vimalnath KV - Search Results

1

Radiosynovectomy of Painful Synovitis of Knee Joints Due to Rheumatoid Arthritis by Intra-Articular Administration of (177)Lu-Labeled Hydroxyapatite Particulates: First Human Study and Initial Indian Experience.

Shinto AS, Kamaleshwaran KK, Chakraborty S, Vyshakh K, Thirumalaisamy SG, Karthik S, Nagaprabhu VN, Vimalnath KV, Das T, Banerjee S. Shinto AS, et al. Among authors: vimalnath kv. World J Nucl Med. 2015 May-Aug;14(2):81-8. doi: 10.4103/1450-1147.153908. World J Nucl Med. 2015. PMID: 26097417 Free PMC article.

2

Practicality of production of ³²P by direct neutron activation for its utilization in bone pain palliation as Na₃[³²P]PO₄.

Vimalnath KV, Shetty P, Chakraborty S, Das T, Chirayil V, Sarma HD, Jagadeesan KC, Joshi PV. Vimalnath KV, et al. Cancer Biother Radiopharm. 2013 Jun;28(5):423-8. doi: 10.1089/cbr.2012.1335. Epub 2013 Apr 23. Cancer Biother Radiopharm. 2013. PMID: 23611187

3

Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.

Chakraborty S, Sarma HD, Vimalnath KV, Pillai MR. Chakraborty S, et al. Among authors: vimalnath kv. Nucl Med Biol. 2013 Oct;40(7):946-54. doi: 10.1016/j.nucmedbio.2013.05.011. Epub 2013 Jul 11. Nucl Med Biol. 2013. PMID: 23850487

4

Large scale production of ⁵¹Cr for medical application in a medium flux research reactor: a comparative investigation of Szilard-Chalmers process and direct (n,γ) route.

Vimalnath KV, Rajeswari A, Chakraborty S, Dash A. Vimalnath KV, et al. Appl Radiat Isot. 2014 Sep;91:104-8. doi: 10.1016/j.apradiso.2014.05.018. Epub 2014 May 28. Appl Radiat Isot. 2014. PMID: 24926944

5

Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.

Chakraborty S, Vimalnath KV, Rajeswari A, Shinto A, Sarma HD, Kamaleshwaran K, Thirumalaisamy P, Dash A. Chakraborty S, et al. Among authors: vimalnath kv. J Labelled Comp Radiopharm. 2014 Jun 15;57(7):453-62. doi: 10.1002/jlcr.3202. J Labelled Comp Radiopharm. 2014. PMID: 24966157 Clinical Trial.

6

Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route.

Vimalnath KV, Chakraborty S, Rajeswari A, Sarma HD, Nuwad J, Pandey U, Kamaleshwaran K, Shinto A, Dash A. Vimalnath KV, et al. Nucl Med Biol. 2015 May;42(5):455-464. doi: 10.1016/j.nucmedbio.2015.01.006. Epub 2015 Jan 22. Nucl Med Biol. 2015. PMID: 25659856

7

Prospects of medium specific activity (177) Lu in targeted therapy of prostate cancer using (177) Lu-labeled PSMA inhibitor.

Chakraborty S, Chakravarty R, Shetty P, Vimalnath KV, Sen IB, Dash A. Chakraborty S, et al. Among authors: vimalnath kv. J Labelled Comp Radiopharm. 2016 Jul;59(9):364-71. doi: 10.1002/jlcr.3414. Epub 2016 Jun 6. J Labelled Comp Radiopharm. 2016. PMID: 27264278

8

Hydroxyapatite (HA) microparticles labeled with (32)P - A promising option in the radiation synovectomy for inflamed joints.

Rajeswari A, Vimalnath KV, Sarma HD, Shetty P, Mohammed SK, Nuwad J, Chakraborty S, Dash A. Rajeswari A, et al. Among authors: vimalnath kv. Appl Radiat Isot. 2016 Oct;116:85-91. doi: 10.1016/j.apradiso.2016.07.022. Epub 2016 Jul 27. Appl Radiat Isot. 2016. PMID: 27501139

9

A "mix-and-use" approach for formulation of human clinical doses of ¹⁷⁷ Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases.

Chakraborty S, Vimalnath KV, Rajeswari A, Chakravarty R, Sarma HD, Radhakrishnan E, Kamaleshwaran K, Shinto AS, Dash A. Chakraborty S, et al. Among authors: vimalnath kv. J Labelled Comp Radiopharm. 2017 Jul;60(9):410-419. doi: 10.1002/jlcr.3517. Epub 2017 Jun 21. J Labelled Comp Radiopharm. 2017. PMID: 28477391

10

Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use ¹⁷⁷Lu-DOTA-TATE: The Intricate Radiochemistry Aspects.

Mathur A, Prashant V, Sakhare N, Chakraborty S, Vimalnath KV, Mohan RK, Arjun C, Karkhanis B, Seshan R, Basu S, Korde A, Banerjee S, Dash A, Sachdev SS. Mathur A, et al. Among authors: vimalnath kv. Cancer Biother Radiopharm. 2017 Sep;32(7):266-273. Cancer Biother Radiopharm. 2017. PMID: 28910148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page